Talks of a near complete US India trade agreement have put fast growing Indian companies back on many watchlists. A deal that lowers tariffs and opens more export doors would give earnings focused businesses extra room to expand without relying only on the local economy. This article looks at three high growth Indian stocks from our screener, where analysts highlight earnings potential and balance sheets they consider capable of supporting that growth.
The three stocks below are just a small sample, with the full screen surfacing 137 more Indian companies that analysts view as having similar earnings potential and balance sheet strength. To identify and analyze the highest conviction ideas in that broader universe, head straight into the Healthy high growth potential screener.
Shaily Engineering Plastics is a precision plastics manufacturer with a heavy tilt toward healthcare, supplying drug delivery devices and CDMO services while generating about ₹10.2b from customised components, and the stock is valued at roughly ₹145.2b in market cap.
For investors focused on the Healthy high growth potential theme, Shaily Engineering Plastics brings a mix of healthcare exposure and earnings momentum that hinges on how successfully its drug delivery platforms scale with demand, which creates an important tension in the growth story.
"Although the GLP-1 opportunity is expanding rapidly worldwide and Shaily has onboarded a large roster of generic players across multiple countries, delays in regulatory approvals or slower than expected generic capture from innovators could cap utilization of its expanded pen capacity and temper healthcare revenue growth."
This raises the question of what happens if one pressure on this healthcare device engine tightens just as expectations for future profit expansion peak.
If that pressure point has you weighing upside against execution risk, read the full narrative for Shaily Engineering Plastics to see how Shaily Engineering Plastics could still accelerate its healthcare engine.
Sky Gold and Diamonds focuses on designing and supplying lightweight gold and diamond jewellery that fits the Healthy high growth potential theme, with about ₹71.8b from gold jewellery manufacturing and a market value near ₹123.0b anchoring that core line of business.
For investors scanning this Healthy high growth potential screen, Sky Gold and Diamonds brings a different angle, tying earnings expectations directly to how effectively its jewellery manufacturing engine converts design demand into profitable, scalable output.
"Accelerating shift from unorganised to organised jewellery retail, supported by lightweight machine made designs and wider national distribution, is deepening wallet share with large chains and is expected to sustain high volume growth. This may help lift revenue and earnings driven by operating leverage."
The real test comes if one key funding assumption shifts just as investors are counting on those higher volumes to feed through to margins.
If that funding risk is what you are weighing, read the full narrative for Sky Gold and Diamonds to see how Sky Gold and Diamonds could still accelerate its jewellery engine.
Timex Group India is a watch specialist that designs, manufactures and sells branded wristwatches across Timex and multiple licensed fashion labels. It generates about ₹8.5b from watches and after-sales service, with a market value near ₹73.9b anchoring its Healthy high growth potential profile.
Timex Group India sits squarely in the Healthy high growth potential theme, with earnings reported to have risen 117% last year and forecasts indicating faster profit expansion than the wider Indian market. However, the premium P/E near 88x means a lot rests on how any pressure on those rich expectations plays out.
When expectations run this hot, read the analysis report for Timex Group India to see what might keep Timex Group India growing fast enough to justify that P/E.
Fresh breakout stories can move fast while they are still under the radar. Momentum shifts, prices start flying, and latecomers can get caught chasing. Acting early can help you avoid being late to the move.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com